Tablet formulation containing meloxicam and Β-cyclodextrin: Mechanical characterization and bioavailability evaluation

AAPS PharmSciTech

Volumn 5, Issue 4, 2004, Pages

  Ghorab, Mamdouh M ^a   Abdel Salam, Heba M ^b   El Sayad, Marwa A ^b   Mekhel, Mohammed M ^b  

^a SUEZ CANAL UNIVERSITY   (Egypt)

^b Medical Union Pharmaceutical Co   (Egypt)

Author keywords

Bioavailability; Meloxican; Solubility; Tablet; CD

Indexed keywords

BETA CYCLODEXTRIN; DRUG VEHICLE; LACTOSE; MELOXICAM; PIROXICAM; BETA CYCLODEXTRIN DERIVATIVE; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COMPRESSIVE STRENGTH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG GRANULATION; DRUG SOLUBILITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MOLECULAR WEIGHT; NORMAL HUMAN; PHYSICAL CHEMISTRY; POROSITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TABLET FORMULATION; BIOAVAILABILITY; BLOOD; CHEMISTRY; COMPARATIVE STUDY; MECHANICS; SOLUBILITY; TABLET;

ADULT; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; HUMANS; MALE; MECHANICS; SOLUBILITY; TABLETS; THIAZINES; THIAZOLES;

EID: 23144462417     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt050459     Document Type: Article

References (19)

1. Moyano JR, Ginés JM, Arias MJ, Rabasco AM. Study of the dissolution characteristics of oxazepam via complexation with β-cyclodextrin. Int J Pharm. 1995;114:95-102.
2. Mukne AP, Nagarsenker MS. Triamterene-β-cyclodextrin systems: preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 2004;5:E19.
3. Nalluri BN, Chowdary KPR, Murthy KVR, Hayman AR, Becket G. Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems. AAPS PharmSciTech. 2003;4:E2.
4. Giordano F, Gazzaniga A, Bettinetti GP, La Manna A. The influence of water content on the binding capacity of β-cyclodextrin. Int J Pharm. 1990;62:153-156.
5. Tasić LJ, Pintye-Hodi K, Sabo-Revesz P. Evaluation of compression behavior of paracetamol tablets produced with β-cyclodextrin dispersions. Part II: Energy distribution study of tablets. Drug Dev Ind Pharm. 1997;23:1153-1158.
6. Naidu NB, Chowdary KP, Murthy KV, Satyanarayana V, Hayman AR, Becket G. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary system. J Pharm Biomed Anal. 2004;35(1):75-86.
7. Baboota S, Agarwal SP. Inclusion complexation of meloxicam with β-cyclodextrin. Indian J Pharm Sci. 2002;64(4):408-411.
8. Nath BS, Shiva Kumar HN. A 2(3) factorial studies on factors influencing meloxicam β-cyclodextrin complexation for better solubility. Indian J Pharm Sci. 2000;Mar-Apr;62(2):129-132.
9. Baboota S, Agarwal SP. Effect of cyclodextrin complexation on the oral bioavailability of meloxicam. Paper presented at the 12th International Cyclodextrin Symposium; May 16-19, 2004; Montpellier, France.
10. Struengmann A, Freudensprung B, Klokkers K inventors. Pharmaceutical compositions of meloxicam with improved solubility and bioavailability. US patent 6284269. 2001.
11. Perissutti B, Rubessa F, Moneghini M, Voinovich D. Formulation design of carbamazepin fast-release tablets prepared by melt granulation. Int J Pharm. 2003;256:53-63.
12. Shah D, Shah Y, Rampradhan M. Development and evaluation of controlled release dilitiazem hydrochloride microparticles using cross-linked poly(vinyl alcohol). Drug Dev Ind Pharm. 1997;23:567-574.
13. Aulton ME. Pharmaceutical Technology. In: Pharmaceutics: The Science of Dosage Form Design. London, UK: Churchill Livingstone; 1988:600-616.
14. Martin A. Micromertics. In: Physical Pharmacy. Philadelphia, PA: Lea and Febiger; 1993:251-283.
15. Reddy KR. Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS PharmSciTech. 2003;4:E61.
16. FDA Center for Drug Evaluation and Research. Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Form. Rockville, MD: FDA; August 1997.
17. Higuchi T, Connors A. Phase-solubility techniques. In: Advances in Analytical Chemistry Instrumentation. Vol 4. New York, NY: Wiley Interscience; 1965: 117-211.
18. El-Shaboury MH. Physical properties and dissolution profiles of tablets directly compressed with β-cyclodextrin. Int J Pharm. 1990;63:95-100.
19. Fenyresi E, Shirankura O, Szejtli J, Nagai T. Properties of cyclodextrin polymer as a tableting aid. Chem Pharm Bull (Tokyo). 1984;32:665-669.